Ra Medical Systems Profit Margin 2018-2019 | RMED
Current and historical gross margin, operating margin and net profit margin for Ra Medical Systems (RMED) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Ra Medical Systems net profit margin as of September 30, 2019 is -797.11%.
|Ra Medical Systems Annual Profit Margins
|Ra Medical Systems Quarterly Profit Margins
||Medical Instruments Manufacturing
Ra Medical Systems, Inc. is a commercial-stage medical device company. It develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company's product pipeline consists of DABRA which is a minimally-invasive excimer laser and disposable catheter system used by physicians as a tool in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease, a form of peripheral artery disease, or above- and below-the-knee. Pharos Excimer Laser is a powerful 308 nm ultraviolet-B excimer laser used by physicians as a tool to treat chronic skin diseases, including psoriasis, vitiligo, atopic dermatitis and leukoderma. Ra Medical Systems, Inc. is based in Carlsbad, California.